QTX3544

· Quanta Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QTX3544, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations [Phase 1]